ResMed Inc. stock gains on RBC upgrade and analyst interest
Published on 09/18/2026 at 17:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
ResMed Inc. stock (ISIN US7611521078) closed at USD 228.68 on the New York Stock Exchange on September 17, 2026, valuing the sleep and respiratory device maker at about USD 33.0 billion.
Analyst moves and institutional interest
According to MarketBeat on September 18, 2026, Bank of America Corp DE disclosed a new stake in ResMed Inc., underlining continued institutional interest in the stock.
The same overview from MarketBeat on September 17, 2026, reports that ResMed Inc. stock carries a consensus analyst rating of Hold with an average price target of USD 241.69, implying potential upside of about 5.7 percent compared with the quoted level.
Valuation and recent performance
Per data cited by MarketBeat on September 17, 2026, ResMed Inc. shares changed hands at USD 228.68, while the 52 week range stood between USD 180.26 and USD 284.87, placing the current price closer to the middle of that band.
The same source notes that ResMed Inc. shares were at USD 240.91 at the beginning of 2026 and have since declined by 5.1 percent to USD 228.68, indicating a modest year to date pullback despite ongoing demand for the company’s sleep apnea and respiratory therapies.
Profitability metrics and earnings power
According to the key metrics presented by MarketBeat on September 17, 2026, ResMed Inc. generated trailing twelve month earnings per share of USD 10.43, resulting in a trailing price to earnings ratio of about 21.93 at the quoted share price.
The same overview highlights that ResMed Inc. reported trailing twelve month net income of USD 1.52 billion with a net margin of 26.94 percent, underscoring the company’s strong profitability profile in the medical equipment sector.
Balance sheet and dividend profile
Data compiled by MarketBeat on September 17, 2026, show that ResMed Inc. has a debt to equity ratio of 0.06, indicating a relatively low leverage level compared with many peers in the broader medical technology space.
The same source notes that the stock offers a dividend yield of 1.15 percent based on the current price, providing income on top of potential capital appreciation for long term shareholders.
Stock price context
On September 17, 2026, ResMed Inc. stock closed at USD 228.68 on the New York Stock Exchange, a level that sits below the recent 52 week high of USD 284.87 and above the 52 week low of USD 180.26, reflecting a recovery from earlier lows but still leaving room relative to past peaks.
ResMed Inc. stock at a glance
- Company: ResMed Inc.
- ISIN: US7611521078
- Ticker: RMD
- Trading venue: NYSE
- Price (as of September 17, 2026, 15:59): 228.68 USD
- Market capitalization: 32.99 billion USD (as of September 17, 2026)
- Sector / Industry: Health Care / Medical Equipment
- Index membership: S and P 500
